Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (SRZN)

CUSIP: 86889P208

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
+1,898,889
SEC-reported price per share
$29.13
Number of holders
58
Value change
+$59,175,029
Number of buys
28
Number of sells
23
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
13,053,283

Security key

86889P208

Report period

Q1 2026

Institutions

58

Top holders

10

Ownership snapshot

Top reported holders of SRZN - Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
COLUMN GROUP III GP, LP
Disclosed value leader
COLUMN GROUP III GP, LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 3/4/5 13F Lead comparable stake: 29% 13D/G row: COLUMN GROUP III GP, LP Showing 1-6 of 15 holder rows.

Quick read

COLUMN GROUP III GP, LP leads the comparable SEC ownership view at 29%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens COLUMN GROUP III GP, LP's linked filing trail.
Comparable ownership Top 5
COLUMN GROUP III GP, LP 29%
TCG Crossover GP II, LLC 13%
Venrock Healthcare Capital Partne... 9.9%
AI Biotechnology LLC 9.9%
5AM Partners VII, LLC 9.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
COLUMN GROUP III GP, LP
13D/G 3/4/5
Tim Kutzkey · 10%+ Owner
29%
$120,704,755
3,824,612 shares
$0 31 Mar 2026
TCG Crossover GP II, LLC
13D/G 3/4/5
Chen Yu · 10%+ Owner
13%
$43,986,796
1,473,101 shares
+$5,944,857 31 Mar 2026
Venrock Healthcare Capital Partners III, L.P.
13D/G
9.9%
$35,981,300
1,205,000 shares
+$9,927,076 31 Mar 2026
AI Biotechnology LLC
13D/G
9.9%
$8,462,521
844,563 shares
$0 24 Mar 2025
5AM Partners VII, LLC
13D/G
9.5%
$34,712,250
1,162,500 shares
+$7,587,814 31 Mar 2026
RA CAPITAL MANAGEMENT, L.P.
13D/G
9.2%
$18,001,245
871,731 shares
+$89,063 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
58
Shares
8,933,216
Rows available
58
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
53
Q1 2026 holders
58
Holder diff
5
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .